KRUSE BO (EVP, CFO, Secy & Treas.) sold 1.6% of their position (4K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $136.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/7/2021ACC: 0001104659-21-089877
DirectorOfficer· EVP, CFO, Secy & Treas.
Since Sep 2018
-4K
Net shares
Net seller
$136.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4K
Price / share
$34.15
Trade value
$136.60K
% of position
1.6%
7/6/2021
245.08K→241.08K
Total
Net shares
−4K
Net value
-$136.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/6/2021 | S · Sale | −4K | $34.15 | $136.60K | 1.6% | 245.08K | 241.08K |
| Total | −4K | -$136.60K | ||||||
Derivative Transactions0
No derivative transactions reported